Introduction {#sec1-1}
============

The introduction of carbapenem for treatment of β-lactam-resistant bacteria is a great achievement in clinical practice.\[[@ref1]\] Carbapenems have been used as the last resort of antimicrobials in the treatment of serious infections caused by Gram-negative bacteria (GNB). However, the clinical use of carbapenem is in danger with the emergence of carbapenemases, particularly metallo-β-lactamase (MBL). MBL has the ability to hydrolyze a wide variety of β-lactam agents, such as penicillins, cephalosporins, and carbapenems. MBLs are inhibited by metal chelators, such as an ethylene diamine tetra acetic acid (EDTA) and thiol-based compounds.\[[@ref2]\]

MBL-encoding genes have been reported worldwide in GNB, such as *Pseudomonas* spp., *Acinetobacter* spp., and members of the *Enterobacteriaceae* family. MBLs spread easily via plasmids and cause nosocomial infections and outbreaks. Such infections mainly concern patients admitted to the intensive care units with several comorbidities.\[[@ref3]\] Therefore, early detection and identification of MBL-producing organisms are of crucial importance for the prevention of nosocomial infection through appropriate treatment.\[[@ref4]\]

Detection of genes coding for MBL by polymerase chain reaction (PCR) usually gives reliable and satisfactory results; however, because of the cost the method, it is of limited practical use for routine diagnostic microbiology laboratories. Thus, a simple and inexpensive testing method for detection of MBL producers is necessary.\[[@ref5]\] The present study was undertaken to detect MBL in GNB using different phenotypic methods.

Materials and Methods {#sec1-2}
=====================

The present study was done in the Department of Microbiology, Teaching Hospital, from August 2012 to September 2012. A total of 107 GNB isolated from various clinical samples including *Escherichia coli*, *Pseudomonas* spp., *Klebsiella* spp., *Acinetobacter* spp., and *Proteus mirabilis* were tested for MBL production. All isolates were subjected to antibiotic susceptibility testing as per the Clinical and Laboratory Standards Institute guidelines.\[[@ref6]\]

Imipenem (IPM)-resistant clinical isolates were taken as positive for MBL screening. Isolates which gave MBL screening test positive were subjected to confirmation by four phenotypic methods using EDTA as MBL inhibitor.

A 0.5 M EDTA solution was prepared by dissolving 18.61 g of EDTA in 100 ml of distilled water\[[@ref1][@ref3][@ref7]\] and 0.1 M EDTA by dissolving 3.72 g of EDTA in 100 ml of distilled water.\[[@ref8]\]

Phenotypic methods used for confirmation of MBL production.

Combined disk synergy test with 0.5 M ethylene diamine tetra acetic acid {#sec2-1}
------------------------------------------------------------------------

Two IPM (10 µg) disks were placed 30 mm apart from center to center on the surface of an agar plate, and 10 µl 0.5 M EDTA solution was added to one of them to obtain the desired concentration of 750 µg.\[[@ref1][@ref3][@ref7]\]

Combined disk synergy test with 0.1 M ethylene diamine tetra acetic acid {#sec2-2}
------------------------------------------------------------------------

Two IPM (10 µg) disks were placed 30 mm apart from center to center on the surface of an agar plate, and 10 µl 0.1 M EDTA solution was added to one of them to obtain the desired concentration of 292 µg.\[[@ref8]\]

In combined disk synergy test (CDST), if zone of inhibition of IPM-EDTA disk was ≥7 mm more than that of IPM disk alone, it was considered as MBL positive.\[[@ref8]\]

Double-disk synergy test with 0.5 M ethylene diamine tetra acetic acid {#sec2-3}
----------------------------------------------------------------------

An IPM (10 µg) disk was placed 20 mm apart from a blank disk containing 10 µl of 0.5 M EDTA (750 µg).\[[@ref3][@ref8]\]

Double-disk synergy test with 0.1 M ethylene diamine tetra acetic acid {#sec2-4}
----------------------------------------------------------------------

An IPM (10 µg) disk was placed 20 mm apart from a blank disk containing 10 μl of 0.1 M EDTA (292 µg).\[[@ref8]\]

In double-disk synergy test (DDST), enhancement of zone of inhibition between IPM and EDTA disk was considered as MBL positive.\[[@ref1][@ref3][@ref7]\]

Results {#sec1-3}
=======

Out of 107 clinical isolates of GNB, 30 isolates were resistant to IPM which were considered as MBL screening positive.

All 30 IPM-resistant isolates were further processed for confirmation by different methods for phenotypic detection of MBL producers. In the present study, out of 107 GNB, 21 (19.62%) isolates were positive for MBL production.

Out of 30 isolates, 21 (70%) isolates were MBL positive by CDST-0.1 M EDTA method, 19 (63.33%) by CDST-0.5 M EDTA method, 17 (56.67%) by DDST-0.1 M EDTA method, and 16 (53.33%) by DDST-0.5 M EDTA method \[[Figure 1](#F1){ref-type="fig"}\].

![Comparison of four phenotypic methods for metallo-β-lactamase detection](JLP-9-81-g001){#F1}

Prevalence of MBL production was highest in *Pseudomonas* spp., followed by *E. coli*, *Klebsiella* spp., *Acinetobacter* spp., and *P. mirabilis* \[[Table 1](#T1){ref-type="table"}\].

###### 

Prevalence of MBL in various isolates
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Polymyxin B was found to be the most sensitive drug. Tetracycline and gentamicin were the least sensitive drugs. All MBL-producing Gram-negative *Bacilli* were resistant to ampicillin/sulbactam \[[Table 2](#T2){ref-type="table"}\].

###### 

Antibiotic sensitivity profile of MBL producing isolates
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Discussion {#sec1-4}
==========

MBL-producing Gram-negative organisms have now been reported in many geographic regions.\[[@ref9]\] In the present study, prevalence of MBL production in GNB was 19.62%. Other studies have reported 14--62.69% MBL prevalence in GNB.\[[@ref1][@ref3][@ref8]\]

The emergence of MBL-producing GNB is challenge to microbiology laboratories because there are no standardized guidelines available to detect them.

MBLs spread easily via plasmids, so they rapidly disseminate within an institution and lead to poor outcomes when infection occurs.\[[@ref10][@ref11][@ref12]\] The detection of MBL-producing GNB is of crucial importance to limit the spread of MBL gene in between bacteria as well as to early start of appropriate treatment.\[[@ref13]\]

Detection of MBL by PCR usually gives reliable and satisfactory results; however, because of the cost the method, it is of limited practical use for routine diagnostic microbiology laboratories. Thus, a simple and inexpensive testing method for detection of MBL producers is necessary.\[[@ref13]\]

In the present study, out of four phenotypic methods using EDTA as inhibitor used for confirmation of MBL production, CDST-0.1 M EDTA was found to be the most sensitive (70.00%) method and DDST-0.5M EDTA was found to be the least sensitive (53.33%) method. Franklin *et al*. have reported 100% sensitivity of CDST-0.1 M EDTA method and 79% sensitivity of DDST-0.1 M EDTA method.\[[@ref8]\]

MBL-positive isolates show resistance to all β-lactam antibiotics, aminoglycosides, tetracycline, and fluoroquinolones.\[[@ref9]\] In the present study, 21 (66.67%) out of 30 isolates were sensitive to polymyxin B. None of the MBL-producing isolates were sensitive to ampicillin/sulbactam. This antibiotic sensitivity pattern of MBL-positive isolates suggests that early detection of MBL-producing GNB and determination of their antibiotic sensitivity are of crucial importance to start of appropriate treatment.

Conclusion {#sec1-5}
==========

CDST-0.1 M EDTA was the most sensitive method for MBL detection in GNB. The method is simple to perform, and the materials used are cheap, nontoxic, and easily accessible, making it highly applicable to routine clinical laboratories.

Limitation {#sec2-5}
----------

In the present study, for confirmation of MBL production, molecular methods were not used.
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